VeonGen Therapeutics GmbH Alternatives & Competitors
12 companies similar to VeonGen Therapeutics GmbH — Dedicated to develop the medicines of the future
Companies similar to VeonGen Therapeutics GmbH
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
GenSight Biologics
Applying pathbreaking science to transform the lives of patients with severe retinal neuro...
Paris, France
Spark Therapeutics, Inc.
This company is now integrated into the Roche Group, united in our commitment to do now wh...
Philadelphia, United Stat...
Annexon Biosciences
Unlocking the Next Generation of Complement Therapies
South San Francisco, Unit...
Track all VeonGen Therapeutics GmbH competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Bedford, United States
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
AGY Therapeutics
Pioneering breakthrough treatments for central nervous system diseases through innovative...
Adverum Biotechnologies
We are on a global mission to establish gene therapy as a new standard of care for the lea...
Redwood City, United Stat...
Renovacor
Advancing transformative therapies for cardiovascular disease
Reviva Pharmaceuticals
Next Generation Therapeutics to successfully address central nervous system, metabolic and...
Cupertino, United States
Carrick Therapeutics
Transformative Cancer Medicines
Dublin, Ireland
Visterra Inc.
We bring better biologics to life. Biospace Best Place to Work 2024!
Waltham, United States
About VeonGen Therapeutics GmbH
VeonGen Therapeutics GmbH, founded in 2017 as a spin-off from Ludwig-Maximilians-University Munich, is a pioneering force in the Biotechnology and Health Care sectors. Based in Germany, the company is committed to developing next-generation therapies with its slogan "Dedicated to develop the medicines of the future." V...
Development of novel gene therapy platforms, Creating in-house pipeline for ophthalmic gene therapy, Partnering with biopharmaceutical companies, Overcoming limitations of existing AAV-based therapies
Biopharmaceutical companies, Healthcare providers focusing on genetic and ophthalmic diseases, Research institutions in genetic engineering and therapeutics
Gene Therapy, AAV Vector Technology, Retinal Disorders, Ophthalmic Diseases, Biopharmaceutical Partnerships, VgAAV Platform, REVeRT Platform, Intravitreal Administration, Transduction Efficiency, Large Gene Mutations, Clinical Ophthalmic Programs, Innovative Therapies, Proprietary Technology, Unmet Medical Needs, Spin-off
B2B, Platform
Licensing, Project Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches VeonGen Therapeutics GmbH and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at VeonGen Therapeutics GmbH on 14 May 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
